Cargando…
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690931/ https://www.ncbi.nlm.nih.gov/pubmed/34987655 http://dx.doi.org/10.7150/thno.68810 |
| _version_ | 1784618706642403328 |
|---|---|
| author | Yan, Libin Ding, Beichen Liu, Haoran Zhang, Yangjun Zeng, Jin Hu, Junhui Yao, Weimin Yu, Gan An, Ruihua Chen, Zhiqiang Ye, Zhangqun Xing, Jinchun Xiao, Kefeng Wu, Lily Xu, Hua |
| author_facet | Yan, Libin Ding, Beichen Liu, Haoran Zhang, Yangjun Zeng, Jin Hu, Junhui Yao, Weimin Yu, Gan An, Ruihua Chen, Zhiqiang Ye, Zhangqun Xing, Jinchun Xiao, Kefeng Wu, Lily Xu, Hua |
| author_sort | Yan, Libin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8690931 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Ivyspring International Publisher |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86909312022-01-04 Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum Yan, Libin Ding, Beichen Liu, Haoran Zhang, Yangjun Zeng, Jin Hu, Junhui Yao, Weimin Yu, Gan An, Ruihua Chen, Zhiqiang Ye, Zhangqun Xing, Jinchun Xiao, Kefeng Wu, Lily Xu, Hua Theranostics Erratum Ivyspring International Publisher 2022-01-01 /pmc/articles/PMC8690931/ /pubmed/34987655 http://dx.doi.org/10.7150/thno.68810 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
| spellingShingle | Erratum Yan, Libin Ding, Beichen Liu, Haoran Zhang, Yangjun Zeng, Jin Hu, Junhui Yao, Weimin Yu, Gan An, Ruihua Chen, Zhiqiang Ye, Zhangqun Xing, Jinchun Xiao, Kefeng Wu, Lily Xu, Hua Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title | Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title_full | Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title_fullStr | Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title_full_unstemmed | Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title_short | Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum |
| title_sort | inhibition of smyd2 suppresses tumor progression by down-regulating microrna-125b and attenuates multi-drug resistance in renal cell carcinoma: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690931/ https://www.ncbi.nlm.nih.gov/pubmed/34987655 http://dx.doi.org/10.7150/thno.68810 |
| work_keys_str_mv | AT yanlibin inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT dingbeichen inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT liuhaoran inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT zhangyangjun inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT zengjin inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT hujunhui inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT yaoweimin inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT yugan inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT anruihua inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT chenzhiqiang inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT yezhangqun inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT xingjinchun inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT xiaokefeng inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT wulily inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum AT xuhua inhibitionofsmyd2suppressestumorprogressionbydownregulatingmicrorna125bandattenuatesmultidrugresistanceinrenalcellcarcinomaerratum |